Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2022 - IJCMAS--ICV 2022: 95.28 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020] For more details click here

Login as a Reviewer


See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 8, Issue:3, March, 2019

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com /
submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2019.8(3): 1582-1586
DOI: https://doi.org/10.20546/ijcmas.2019.803.183


Speciation of Candida Isolated among Immunocompromised Patients
S. Meenakshi1 and R. Vidhya Rani2*
1Department of Microbiology, Madras Medical College, Chennai, Tamilnadu, India
2Department of Microbiology Govt Mohankumaramangalam Medical College, Salem, Tamilnadu, India
*Corresponding author
Abstract:

Immune-compromised patients have lead to rise in infections caused by Candida albicans and by Non Candida albicans. This study was done with 368 samples from 300 immunocompromised patients. The most common species isolated was C. albicans (42%), followed by C. tropicalis (35%), C. pseudotropicalis (5%), C. krusei (5%), C. glabarata (4%), C. parapsilosis (3%), C. guilliermondii (2%). CHROM agar candida medium was used in identification of Candida species. It is very important to identify these pathogens at the species level from all the clinical specimens received at laboratory for effective treatment.


Keywords: Candida, Immuno-compromised Patients

Download this article as Download

How to cite this article:

Meenakshi, S. and Vidhya Rani, R. 2019. Speciation of Candida Isolated among Immunocompromised Patients.Int.J.Curr.Microbiol.App.Sci. 8(3): 1582-1586. doi: https://doi.org/10.20546/ijcmas.2019.803.183
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

Citations